Evidence map›Paper›PMID 41282683›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records.

Federica Corso, Vittoria Peppoloni, Laura Mazzeo, Giuseppe Leone, Luana Passos, Vanja Mišković, Justin Armanini, Alberto Ferrarin, Isabella Catharina Wiest, Fabian Wolf and 34 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors.

Federica CorsoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-4947-9628
Vittoria PeppoloniDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0009-0006-1178-6952
Laura MazzeoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0001-9226-8861
Giuseppe LeoneDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0009-0008-9931-9332
Luana PassosSchool of Medicine, University of Minho, Braga, Portugal.
Vanja MiškovićDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0003-1475-0243
Justin ArmaniniUniversity of Milano-Bicocca, Milan, Italy.ORCID 0009-0003-3173-4971
Alberto FerrarinDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0009-0004-8915-5750
Isabella Catharina WiestElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0009-0004-4848-614X
Fabian WolfElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Giulia MontelaticiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0009-0001-7660-7998
Rebecca RomanòDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-1644-1981
Ambrosini PaoloDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0009-0003-8200-2623
Tommaso CapocciaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Stefano NatangeloDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0009-0002-3021-3085
Simone RotaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-6839-1488
Paola AndenaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Marta De PontiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Alessandra RussoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Giulia StasiSchool of Medicine and Surgery, University of Milan, Italy.
Leonardo ProvenzanoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0001-9208-2039
Andrea SpagnolettiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-5293-1849
Marco Meazza PrinaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0009-0005-3159-0714
Chiara CavalliDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Claudia GianiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Roberta SerinoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Michele BorracinoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Chiara BonalumeDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Rosa Maria di MauroDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Claudia AgostaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Andra Diana DumitrascuDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Giorgia Di LibertiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0009-0000-1889-7520
Giulia CorraoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-5757-6073
Teresa BeninatoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Monica GanzinelliDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-0526-0835
Mario OcchipintiDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-7169-5343
Marta BrambillaDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0003-1148-7056
Claudia ProtoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0003-0287-9787
Jakob Nicholas KatherElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0000-0002-3730-5348
Alessandra Laura Giulia PedrocchiDepartment of Electronic, Information and Bioengineering, Politecnico di Milano, Milan, Italy.ORCID 0000-0001-9957-2786
Filippo De BraudDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0003-0103-730X
Giuseppe Lo RussoDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0003-3224-2728
Paolo BailiDepartment of Epidemiology and Data Science, Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0003-0335-2418
Arsela PrelajDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0002-3863-088X

Funding

Integration of epidemiology, pathology, immunology and outcomes in colorectal cancerR01CA263318 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI STEPHEN B GRUBER · 2022 to 2026
$3.4M
NCI NIH HHS R01 CA263318
6 · The paper itself

Abstract

Real-world data (RWD), largely stored in unstructured electronic health records (EHRs), are critical for understanding complex diseases like cancer. However, extracting structured information from these narratives is challenging due to linguistic variability, semantic complexity, and privacy concerns. This study evaluates the performance of four locally deployable and small language models (SLMs), LLaMA, Mistral, BioMistral, and MedLLaMA, for information extraction (IE) from Italian EHRs within the APOLLO 11 trial on non-small cell lung cancer (NSCLC). We examined three prompting strategies (zero-shot, few-shot, and annotated few-shot) across English and Italian, involving clinicians with varying expertise to assess prompt design's impact on accuracy. Results show that general-purpose models (e.g., LLaMA 3.1 8B) outperform biomedical models in most tasks, particularly in extracting binary features. Multiclass variables such as TNM staging, PD-L1, and ECOG were more difficult due to implicit language and lack of standardization. Few-shot prompting and native-language inputs significantly improved performance and reduced hallucinations. Clinical expertise enhanced consistency in annotation, particularly among students using annotated examples. The study confirms that privacy-preserving SLMs can be deployed locally for efficient and secure cancer data extraction. Findings highlight the need for hybrid systems combining SLMs with expert input and underline the importance of aligning clinical documentation practices with SLM capabilities. This is the first study to benchmark SLMs on Italian EHRs and investigate the role of clinical expertise in prompt engineering, offering valuable insights for the future integration of SLMs into real-world clinical workflows.

Indexed as

electronic health recordsentity recognitionLarge-Language ModelsNon Small Cell Lung Cancer

Identifiers

PMID41282683
PMCPMC12633604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.